AI-Enhanced Monitoring: Assessing Clinical Quality of Subjective Data
Monday, September 29, 2025 4:15 PM to 4:45 PM · 30 min. (America/New_York)
Room: 339+340
Product Showcase
Information
How artificial intelligence is revolutionizing data quality assurance for subjective clinical endpoints that make or break regulatory submissions
The Problem: Clinical trials rely heavily on subjective assessments (MMSE, ADAS-Cog, MDRAS) for primary endpoints, but traditional quality review methods leave 80-90% of these critical assessments unchecked due to resource constraints.
The Solution: Our AI-enhanced review system analyzes 100% of assessment recordings, automatically flagging potential administration and scoring issues for targeted intervention.
